
ELON MUSK IS TOUTING NEW ADVANCEMENTS MADE BY ONE OF HIS COMPANIES.
NOT TESLA OR SPACE X —
BUT AT “NEURALINK.”
MUSK SAYS THE NEURO-TECH COMPANY HAS SUCCESSFULLY IMPLANTED A COMPUTER CHIP INTO A HUMAN BRAIN FOR THE FIRST TIME.
POSTING ON X – ANOTHER ONE OF HIS PROPERTIES – MUSK SAYS THE PATIENT RECEIVED THE IMPLANT ON SUNDAY AND IS “RECOVERING WELL.”
MUSK SAID INITIAL RESULTS SHOW “PROMISING NEURON SPIKE DETECTION” – BUT GAVE NO FURTHER DETAILS.
LAST MAY – NEURALINK RECEIVED APPROVAL FROM THE FDA TO CONDUCT ITS FIRST IN-HUMAN CLINICAL STUDY.
MUSK ALSO ANNOUNCED THE FIRST NEURALINK PRODUCT WILL BE CALLED “TELEPATHY” — AND WILL ALLOW A PATIENT TO USE A PHONE OR COMPUTER TO CONTROL ANY DEVICE – JUST BY THINKING.
MUSK SAID INITIAL USERS WILL BE THOSE WHO HAVE LOST THE USE OF THEIR LIMBS.